STERIS (STE)
(Delayed Data from NYSE)
$228.77 USD
+4.48 (2.00%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $228.84 +0.07 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for STERIS plc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 5,139 | 4,958 | 4,585 | 3,108 | 3,031 |
Cost Of Goods | 2,921 | 2,798 | 2,569 | 1,764 | 1,711 |
Gross Profit | 2,218 | 2,160 | 2,016 | 1,343 | 1,320 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,382 | 1,892 | 1,591 | 795 | 783 |
Income After Depreciation & Amortization | 836 | 268 | 426 | 548 | 537 |
Non-Operating Income | 11 | -3 | -22 | 6 | 2 |
Interest Expense | 144 | 108 | 90 | 37 | 40 |
Pretax Income | 703 | 157 | 315 | 518 | 499 |
Income Taxes | 150 | 52 | 72 | 121 | 91 |
Minority Interest | 2 | -1 | -1 | -1 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 553 | 106 | 243 | 397 | 408 |
Extras & Discontinued Operations | -173 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 378 | 107 | 244 | 397 | 408 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,406 | 1,319 | 1,045 | 768 | 734 |
Depreciation & Amortization (Cash Flow) | 570 | 1,051 | 620 | 219 | 197 |
Income After Depreciation & Amortization | 836 | 268 | 426 | 548 | 537 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 99.36 | 100.25 | 98.33 | 85.90 | 85.64 |
Diluted EPS Before Non-Recurring Items | 8.20 | 8.20 | 7.92 | 6.17 | 5.64 |
Diluted Net EPS (GAAP) | 3.81 | 1.07 | 2.48 | 4.63 | 4.76 |
Fiscal Year end for STERIS plc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 1,116.15 | 1,395.65 | 1,342.36 | 1,284.54 |
Cost Of Goods | NA | 667.58 | 793.05 | 748.83 | 711.08 |
Gross Profit | NA | 448.58 | 602.59 | 593.53 | 573.46 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 203.35 | 386.43 | 407.67 | 384.58 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 245.23 | 216.16 | 185.86 | 188.88 |
Non-Operating Income | NA | 6.33 | 2.08 | 1.24 | 1.39 |
Interest Expense | NA | 36.10 | 38.95 | 36.94 | 32.36 |
Pretax Income | NA | 215.45 | 179.29 | 150.15 | 157.91 |
Income Taxes | NA | 43.25 | 38.34 | 33.81 | 34.12 |
Minority Interest | NA | 0.38 | 0.20 | 1.03 | 0.24 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 172.20 | 140.95 | 116.35 | 123.79 |
Extras & Discontinued Operations | NA | -154.30 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.38 | 140.74 | 115.32 | 123.55 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 99.44 | 99.35 | 99.41 | 99.24 |
Diluted EPS Before Non-Recurring Items | NA | 2.41 | 2.22 | 2.03 | 2.00 |
Diluted Net EPS (GAAP) | NA | -0.02 | 1.42 | 1.16 | 1.25 |